Treatment of B-cell disorder improves renal outcome of patients with monoclonal gammopathy–associated C3 glomerulopathySophie Chauvet, Frank Bridoux, Véronique Frémeaux-Bacchi et al.|Blood|2017Cited by 183
Preemptive rituximab prevents long-term relapses in immune-mediated thrombotic thrombocytopenic purpuraMatthieu Jestin, Paul Coppo, Y. Benhamou et al.|Blood|2018Cited by 163
Cardiac troponin‐I on diagnosis predicts early death and refractoriness in acquired thrombotic thrombocytopenic purpura. Experience of the French Thrombotic Microangiopathies Reference CenterY. Benhamou, Lautrette Alexandre, Pierre‐Yves Boëlle et al.|Journal of Thrombosis and Haemostasis|2014Cited by 139
Atypical and secondary hemolytic uremic syndromes have a distinct presentation and no common genetic risk factorsAlice Le Clech, Fádi Fakhouri, Noémie Simon‐Tillaux et al.|Kidney International|2019Cited by 119
Both Monoclonal and Polyclonal Immunoglobulin Contingents Mediate Complement Activation in Monoclonal Gammopathy Associated-C3 GlomerulopathySophie Chauvet, Véronique Fremeaux-Bacchi, Lubka T. Roumenina et al.|Frontiers in Immunology|2018Cited by 85